This site is intended for healthcare professionals only
LoginRegister
Palamur Biosciences Faces USFDA Warning for Multiple GLP Compliance FailuresUSFDA accepts under priority review GSK application to extend indication of adjuvanted RSV vaccine
Lupin receives positive EMA comittee opinion for eye therapy RanluspecLupin posts bigger-than-expected rise in Q3 profit
NPPA Finally Allows GSK to Discontinue Grisovin FPGSK application for Shingrix for shingles prevention in at-risk adults aged 18 and over accepted for...
Gilead Sciences exercises option to license Assembly Biosciences Helicase-Primase Inhibitor programs for recurrent genital herpesGilead Sciences blood cancer therapy trials put on hold by USFDA
Aurobindo Pharma arm Unit IV gets 5 USFDA observationsPiramal Pharma gets 3 USFDA observations for US facility
NPPA Fixes Ceiling Prices for 6 Life-Saving Drugs Including Immunoglobulin, Dialysis Fluids, RiboflavinNPPA fixes price for various FDCs having Sitagliptin, Linagliptin
CDSCO Panel Clears Bristol Myers Yervoy for Two New Cancer IndicationsCDSCO Panel Grants Bristol-Myers Squibb's Protocol Amendment proposal for Mavacamten
MSD Pharma gets CDSCO panel nod for New Indications of Pembrolizumab in IndiaMSD NOT involved in Poonam Pandey fake death stunt: Makers of Gardasil clarify, cut ties with agency...
Jubilant Generics invests Rs 20 lakh in Jubilant Pharma CanadaNovo Nordisk parent invests in India's Manipal hospital chain
JB Pharma net profit rises 26 percent to Rs 134 crore for Q3JB Pharma net profit rises 26 percent to Rs 134 crore for Q3
USFDA Approves Bionpharmas Generic HIV Drug EtravirineUSFDA gives tentative nod to Biocon for cancer drug Dasatinib
Lupin receives positive EMA comittee opinion for eye therapy RanluspecLupin bags USFDA nod for Bromfenac Ophthalmic Solution, 0.075%
X